Pathogenesis and manifestations of human herpesvirus-8 associated disorders

被引:23
作者
Aoki, Y [1 ]
Tosato, G [1 ]
机构
[1] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1016/S0037-1963(03)70006-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human herpesvirus-8 (HHV-8), a recently discovered oncogenic human virus, is consistently associated with Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman's disease (MCD). These disorders occur more frequently, but not exclusively, in human immunodeficiency virus (HIV)-infected individuals, and exhibit more aggressive clinical courses when developing in the setting of acquired immunodeficiency syndrome (AIDS). One of the most intriguing aspects of HHV-8-related disorders is the involvement of numerous growth factors in their pathogenesis. This review will focus on several HHV-8 gene products that exhibit proinflammatory and proangiogenic activities or act as transcriptional activators of cellular cytokines that are involved in the pathogenesis of HHV-8-related disorders.
引用
收藏
页码:143 / 153
页数:11
相关论文
共 87 条
[1]  
Albini A, 1996, ONCOGENE, V12, P289
[2]   The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells [J].
Albini, A ;
Soldi, R ;
Giunciuglio, D ;
Giraudo, E ;
Benelli, R ;
Primo, L ;
Noonan, D ;
Salio, M ;
Camussi, G ;
Rockl, W ;
Bussolino, F .
NATURE MEDICINE, 1996, 2 (12) :1371-1375
[3]   Prevalence of antibodies to human herpesvirus 8 (HHV-8) in saudi arabian patients with and without renal failure [J].
Almuneef, M ;
Nimjee, S ;
Khoshnood, K ;
Miller, G ;
Rigsby, MO .
TRANSPLANTATION, 2001, 71 (08) :1120-1124
[4]   Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas [J].
Aoki, Y ;
Tosato, G .
BLOOD, 1999, 94 (12) :4247-4254
[5]   Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma [J].
Aoki, Y ;
Feldman, GM ;
Tosato, G .
BLOOD, 2003, 101 (04) :1535-1542
[6]   Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 [J].
Aoki, Y ;
Jaffe, ES ;
Chang, Y ;
Jones, K ;
Teruya-Feldstein, J ;
Moore, PS ;
Tosato, G .
BLOOD, 1999, 93 (12) :4034-4043
[7]   Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus [J].
Aoki, Y ;
Narazaki, M ;
Kishimoto, T ;
Tosato, G .
BLOOD, 2001, 98 (10) :3042-3049
[8]   Vascular endothelial growth factor/vascular permeability factor in the pathogenesis of primary effusion lymphomas [J].
Aoki, Y ;
Tosato, G .
LEUKEMIA & LYMPHOMA, 2001, 41 (3-4) :229-+
[9]   Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders [J].
Aoki, Y ;
Yarchoan, R ;
Wyvill, K ;
Okamoto, S ;
Little, RF ;
Tosato, G .
BLOOD, 2001, 97 (07) :2173-2176
[10]   Serum viral interleukin-6 in AIDS-related multicentric Castleman disease [J].
Aoki, Y ;
Tosato, G ;
Fonville, TW ;
Pittaluga, S .
BLOOD, 2001, 97 (08) :2526-2527